Finasteride has been FDA-approved for male pattern hair loss since 1997 with a 25-year safety record. Here’s what it actually does in the body, what the clinical data shows, and what to realistically expect.
By Dr. Teja V. Surapaneni, MD, MS • Board-Certified Internal Medicine (ABIM) • Licensed NV, WA, OR, WI • May 2026
Male pattern hair loss (androgenetic alopecia) is driven primarily by dihydrotestosterone (DHT) — a potent androgen derived from testosterone through the action of an enzyme called 5-alpha reductase. DHT binds to androgen receptors in genetically susceptible hair follicles, progressively shrinking them over time. This process, called follicular miniaturization, gradually turns thick terminal hairs into thin vellus hairs, and eventually causes follicular dormancy.
The rate and pattern of loss is largely genetic and inherited from both sides of the family — not just the maternal line as is commonly believed. But DHT is the biochemical trigger, and blocking DHT is the mechanism finasteride exploits.
Finasteride is a 5-alpha reductase inhibitor. It blocks the enzyme responsible for converting testosterone into DHT, reducing scalp DHT levels by approximately 60–70%. With less DHT available, the follicular miniaturization process slows dramatically — and in many patients partially reverses.
Importantly, finasteride doesn’t regrow hair from scratch. It works by preserving follicles that are still active and allowing partially miniaturized follicles to recover. Starting earlier in the hair loss process produces better results than starting after significant follicle loss has already occurred.
In the pivotal Phase 3 trials for finasteride 1 mg in male pattern hair loss:
The medication must be taken consistently. Discontinuing finasteride results in DHT levels returning to baseline within weeks, and the hair loss process resumes — often with accelerated shedding in the months following discontinuation.
Finasteride 1 mg is FDA-approved for men with androgenetic alopecia. It is contraindicated in women who are pregnant or may become pregnant due to risk of fetal harm. It is most effective for men with hair loss at the crown and mid-scalp — limited effectiveness on a fully receded hairline where follicles are dormant.
The ideal candidate is a man in his 20s through 50s with active, progressive hair loss who still has functioning follicles in the affected areas.
The most discussed side effects of finasteride are sexual — reduced libido, erectile dysfunction, and reduced ejaculate volume — and occur in approximately 2–4% of men in clinical trials (compared to roughly 1% on placebo). These effects are reversible upon discontinuation in the vast majority of cases.
Post-finasteride syndrome — the claim that sexual side effects persist permanently after stopping — remains scientifically contested. The evidence for persistent effects after discontinuation is not robust in the peer-reviewed literature, and the major medical bodies that have reviewed the evidence have not identified a confirmed causal mechanism. Our physicians discuss this openly during consultation.
For the 96–98% of men who don’t experience sexual side effects, finasteride is a low-burden, once-daily oral medication with a strong 25-year safety record.
For men with moderate to significant hair loss, combination therapy — finasteride (addressing the androgen pathway) plus minoxidil (a topical vasodilator that stimulates follicle activity via a separate mechanism) — produces better outcomes than either medication alone. YourMD offers both as individual prescriptions and as a combined hair restoration bundle.
Our hair restoration program starts with a physician consultation with a board-certified MD. Finasteride is available at 1 mg daily. Minoxidil (topical 5%, or oral where appropriate) is available separately or in combination. Your physician will recommend the right approach based on your degree of hair loss, timeline, and health history.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Consult a qualified physician before starting any prescription medication. Page medically reviewed by Teja V. Surapaneni, MD, MS — Board-Certified Internal Medicine (NV, WA, OR, WI). Last reviewed: May 2026.